Trials / Sponsors / NorthSea Therapeutics B.V.
NorthSea Therapeutics B.V.
Industry · 7 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD). Intestinal Failure Associated Liver Disease | Phase 2 | 2024-01-15 |
| Completed | Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With Hypertriglyceridemia High Triglycerides | Phase 2 | 2023-06-30 |
| Completed | Open-label Study to Evaluate the Effects of NST-1024 on the PK of Multiple Drugs in Healthy Subjects Healthy Volunteers | Phase 1 | 2022-07-19 |
| Completed | Study of NST-6179 in Healthy Subjects Short Bowel Syndrome, Parenteral Nutrition Associated Liver Disease | Phase 1 | 2021-11-11 |
| Completed | A Phase 1, First Time in Humans Study of NST-1024 Hypertriglyceridemia | Phase 1 | 2020-10-27 |
| Completed | A Phase 2b Study of Icosabutate in Fatty Liver Disease Non Alcoholic Steatohepatitis (NASH) | Phase 2 | 2019-07-17 |
| Completed | A Study to Evaluate the Effects of NST-4016 on QT/Corrected QT (QTc) Interval Dyslipidemias | Phase 1 | 2018-06-15 |